Axa S.A. Spring Works Therapeutics, Inc. Transaction History

Axa S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 14, 2023	SELL	$18.36 - $60.07 $38,170 - $124,885	-2,079 Reduced 1.91%	107,022 $2.63 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $38,170 - $124,885	-2,079 Reduced 1.91%	107,022 $2.64 Million
Q1 2022 Feb 14, 2023	BUY	$48.97 - $65.46 $5.34 Million - $7.14 Million	109,101 New	109,101 $6.16 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $48 - $65	1 Added 0.0%	109,101 $6.16 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $69,503 - $98,895	1,304 Added 1.21%	109,100 $6.76 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $248,885 - $350,568	3,972 Added 3.83%	107,796 $6.84 Million
Q2 2021 Aug 13, 2021	SELL	$67.45 - $85.63 $531,843 - $675,192	-7,885 Reduced 7.06%	103,824 $8.56 Million
Q1 2021 May 14, 2021	BUY	$65.1 - $93.59 $7.27 Million - $10.5 Million	111,709 New	111,709 $8.22 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.